TMS for Inhibition Enhancement in Schizophrenia - Trial NCT06155682
Access comprehensive clinical trial information for NCT06155682 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Maryland, Baltimore and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 34 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Maryland, Baltimore
Timeline & Enrollment
N/A
Mar 01, 2025
Dec 01, 2028
Primary Outcome
The change in the short interval intracortical inhibition (SICI) score
Summary
This study purpose is to perform a pilot mechanistic trial repetitive transcranial magnetic
 stimulation (rTMS) clinical trial in 34 people with schizophrenia (Sz). The trial will
 evaluate whether inhibitory 1 Hertz (Hz) rTMS targeting motor cortex can increase brain
 inhibition reflected in a decrease in the short-interval intracortical inhibition (SICI)
 score from pre-to-post-treatment. We will also collect preliminary data on the effect of rTMS
 on the resting functional connectivity of the motor cortex and other brain regions and the
 relationship of change in SICI to change in cognitive performance
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06155682
Device Trial